This intervention reduced resistance to nonnucleoside reverse transcriptase inhibitors at 6 weeks after delivery by half, suggesting it should be considered as an adjuvant to intrapartum nevirapine. Medscape Medical News
A study shows that 2.4 g/day of mesalazine with Multi Matrix Technology in a single dose is as effective as the twice-daily dose in achieving maintenance of remission for ulcerative colitis. Medscape Medical News
Temsirolimus has shown significant activity in the treatment of relapsed or refractory mantle cell lymphoma in a phase 3 clinical trial. Medscape Medical News
Preliminary brain-imaging findings suggest that bipolar disorder develops in adolescence; future treatments may prevent progression of these brain changes. Medscape Medical News
This column provides a brief overview on the evaluation of IBS patients with constipation, with an emphasis on the signs and symptoms that warrant referral to a gastroenterologist. Medscape Gastroenterology